Xellia and Kabi Broaden US Antibiotics Offering

New Offerings Of Vancomycin And Ertapenem

 
• By Aidan Fry

Xellia has added a 500mg/100ml variant to its range of vancomycin ready-to-use bags in the US, while Kabi has introduced ertapenem 1g vials and struck a critical-care supply deal with Vizient.

Syringes
Xellia and Fresenius Kabi have expanded their injectable antibiotics portfolio in the US • Source: Shutterstock

More from Products

More from Generics Bulletin